Alan T. Remaley
National Institutes of Health(US)Government of the United States of America(US)LabCorp (United States)(US)National Heart Lung and Blood Institute(US)National Institutes of Health Clinical Center(US)
Publications by Year
Research Areas
Lipoproteins and Cardiovascular Health, Cholesterol and Lipid Metabolism, Diabetes, Cardiovascular Risks, and Lipoproteins, Cancer, Lipids, and Metabolism, Drug Transport and Resistance Mechanisms
Most-Cited Works
- → MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins(2011)2,678 cited
- → PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway(2001)1,162 cited
- → Cholesterol Efflux and Atheroprotection(2012)941 cited
- → Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points—a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine(2016)811 cited
- → A New Equation for Calculation of Low-Density Lipoprotein Cholesterol in Patients With Normolipidemia and/or Hypertriglyceridemia(2020)526 cited
- → HDL Measures, Particle Heterogeneity, Proposed Nomenclature, and Relation to Atherosclerotic Cardiovascular Events